Breaking news

Starlink, Deutsche Telekom Plan Direct-To-Cell Satellite Service In Europe

Strategic Partnership And Vision

SpaceX’s Starlink has joined forces with German telecommunications powerhouse Deutsche Telekom to launch a revolutionary satellite-based mobile service across 10 European countries. Set to debut in 2028, this collaboration is designed to extend mobile connectivity to remote areas where traditional network expansion faces significant challenges, including restricted zones due to environmental regulations and difficult geographic terrain.

Technological Advancements With Second-Generation Satellites

The upcoming service will be the first in Europe to integrate Starlink’s advanced second-generation V2 satellites. With this pioneering technology, the initiative promises to enhance mobile communications by delivering data, voice, and messaging services directly to mobile devices, paving the way for enhanced broadband accessibility in even the most underserved regions.

Expanding European Connectivity

The service rollout will span across Germany, Austria, Poland, Hungary, the Czech Republic, Slovakia, Greece, Croatia, Montenegro, and North Macedonia. This strategic expansion highlights the companies’ commitment to bridging the digital divide and underscores their vision to empower communities by overcoming geographical hurdles through innovative technology.

Market Implications And Future Prospects

SpaceX, which owns Starlink, continues to influence the global telecommunications landscape, boasting around 9,000 satellites and approximately 9 million customers. This move coincides with growing investor interest, as recent reports suggest SpaceX is aiming for an IPO later this year with ambitions to raise up to $50 billion at a valuation possibly reaching $1.5 trillion. Additional developments include regulatory approvals for the deployment of another 7,500 V2 satellites and notable collaborations, such as Microsoft’s initiative to connect community hubs in Kenya, further solidifying Starlink’s role as a catalyst for global connectivity.

EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

Aretilaw firm
The Future Forbes Realty Global Properties
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter